These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11994885

  • 1. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R, Gibson B, Procyshyn RM, Kang N.
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K, Leinonen E.
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Olanzapine and neuroleptic malignant syndrome.
    Tofler I.
    Psychosomatics; 2002 Sep; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract] [Full Text] [Related]

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J, Bermúdez García JM, Alvarez García ML, Rico Irles J.
    Med Clin (Barc); 2000 Sep 09; 115(7):279. PubMed ID: 11013157
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome associated with olanzapine therapy.
    Apple JE, Van Hauer G.
    Psychosomatics; 1999 Sep 09; 40(3):267-8. PubMed ID: 10341541
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR, Vingerhoets FJ, Alberque C, Landis T.
    Arch Gen Psychiatry; 1999 Jan 09; 56(1):101-2. PubMed ID: 9892264
    [No Abstract] [Full Text] [Related]

  • 9. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K, Alderman CP.
    Ann Pharmacother; 2000 May 09; 34(5):667. PubMed ID: 10852098
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome and low-dose olanzapine.
    Suh H, Bronson B, Martin R.
    Am J Psychiatry; 2003 Apr 09; 160(4):796. PubMed ID: 12668376
    [No Abstract] [Full Text] [Related]

  • 11. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA, Adam LA, Frank FM, Carney-Doebbeling C.
    Psychosomatics; 2001 Apr 09; 42(6):528-9. PubMed ID: 11815691
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A, Köster J, Schulz A, Krömker H, Becker T.
    Psychiatr Prax; 2003 Jul 09; 30(5):279-82. PubMed ID: 12872187
    [Abstract] [Full Text] [Related]

  • 14. Neuropletic malignant syndrome and olanzapine.
    Sierra-Biddle D, Herran A, Diez-Aja S, Gonzalez-Mata JM, Vidal E, Diez-Manrique F, Vazquez-Barquero JL.
    J Clin Psychopharmacol; 2000 Dec 09; 20(6):704-5. PubMed ID: 11106147
    [No Abstract] [Full Text] [Related]

  • 15. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D, Bristow MF.
    Br J Psychiatry; 1999 Oct 09; 175():392-3. PubMed ID: 10789314
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
    Margolese HC, Chouinard G.
    Am J Psychiatry; 1999 Jul 09; 156(7):1115-6. PubMed ID: 10401467
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA, McDougall BC, Ercan-Fang N, Billington CJ.
    Ann Pharmacother; 1998 Nov 09; 32(11):1158-9. PubMed ID: 9825080
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL, Taylor WH, Ware MR.
    Psychopharmacol Bull; 2001 Nov 09; 35(3):49-54. PubMed ID: 12397878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.